Zakara Biotechnology Fund Ltd. — Form D/A
Zakara Biotechnology Fund Ltd. of CAMANA BAY, E9, a pooled investment fund, filed a Form D amendment with the SEC on 2026-04-17. $100.0M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2026-04-17
- Form: D/A
- Accession: 0000919574-26-002294
- Industry: Pooled Investment Fund
- Exemptions: 06b,3C,3C.7
- Amount sold: $100.0M
- Minimum investment: $100K
- Investors: 1
- Security types: equity, fund interests
- SEC file number: 021-543717
Issuer
- Name: Zakara Biotechnology Fund Ltd.
- CIK: 0002064139
- Entity type: Other
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2025
- Address: C/O OGIER GLOBAL (CAYMAN) LTD 89 NEXUS WAY, CAMANA BAY, E9, KY1-9009
- Phone: 646 419 8761
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Ekwutozia Nwabuzor | Related Person | New York, NY |
| Janet Okogbaa | Related Person | New York, NY |
| - Zakara Capital LLC | Executive Officer | New York, NY |
| - Zakara Capital LLC | Promoter | New York, NY |
| Sabera Loughran | Director | Camana Bay, E9 |
| Janet Okogbaa | Director | New York, NY |
| - Zakara Biotechnology Fund GP LLC | Executive Officer | New York, NY |
| - Zakara Biotechnology Fund GP LLC | Promoter | New York, NY |
Other filings by this issuer (1)
More